[144] Nixxy, Inc. SEC Filing
Form 144 notice reporting a proposed sale of 49,782 common shares with an aggregate market value of $78,655. The sale is scheduled approximately for 09/23/2025 on NASDAQ. The filing shows the securities were acquired on 01/15/2015 as founders shares from the issuer and the payment/consideration is recorded as NA. The filer reports nothing to report for securities sold in the past three months. The notice includes the standard representation that the seller does not possess undisclosed material adverse information and references possible reliance on a Rule 10b5-1 plan if applicable.
- Full disclosure of sale details: quantity, aggregate value, exchange, and approximate date are provided
- Securities were acquired as founders shares with acquisition date stated (01/15/2015)
- No sales in the past three months, indicating this is not part of a recent active disposal
- None.
Insights
TL;DR: Routine Form 144 disclosing an intended sale of 49,782 common shares valued at $78,655, acquired as founders shares in 2015.
This filing is procedural: it notifies the market of an intended resale under Rule 144. Key facts are the quantity, 49,782 shares, the aggregate value $78,655, and the approximate sale date 09/23/2025. There are no reported sales in the prior three months, which suggests this is not part of an ongoing disposal program. Absent additional context on the filer’s holdings or company capitalization, the disclosure by itself is informational rather than market-moving.
TL;DR: Standard insider resale notice; acquired as founders shares in 2015 and accompanied by required attestation about undisclosed material information.
The filing documents that the shares were originally issued by the issuer as founders shares on 01/15/2015, which is relevant to transferability under Rule 144. The inclusion of the signature attestation and the absence of recent sales comply with expected Rule 144 disclosure practices. No governance concerns or material regulatory issues are evident from the content provided.